GlassScriptPhysician profile
Kathy N Cooley
NPI 1710176946
$5,655.26
in general payments reported to CMS, 2019-2025
34 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $958 · 2022: $1,036 · 2023: $1,434 · 2024: $956 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,660.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,847.90 | 2021-2025 | |
| Ironwood Pharmaceuticals, INC | $607.10 | 2021-2024 | Linzess |
| Otsuka America Pharmaceutical, INC. | $527.23 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Mycite |
| Astrazeneca Pharmaceuticals LP | $417.08 | 2021-2025 | Airsupra, Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $356.77 | 2022-2025 | Caplyta |
| Glaxosmithkline, LLC. | $324.36 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Indivior INC. | $202.61 | 2024-2025 | Sublocade |
| Uswm, LLC | $200.25 | 2023-2024 | Lucemyra, Zimhi |
| Takeda Pharmaceuticals U.S.A., INC. | $97.69 | 2021-2023 | Trintellix |
| Exact Sciences Corporation | $97.14 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $94.93 | 2021-2025 | Rybelsus, Ozempic |
| Braeburn INC. | $88.20 | 2024 | Brixadi |
| Pfizer INC. | $82.12 | 2021-2023 | |
| Lundbeck LLC | $74.92 | 2024-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $60.70 | 2021-2023 | Xarelto |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $55.15 | 2023 | Aristada, Lybalvi |
| Gilead Sciences, INC. | $55.08 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $45.80 | 2021-2023 | |
| Horizon Therapeutics Plc | $45.68 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $44.42 | 2021 | |
| Orexo US, INC. | $39.99 | 2024-2025 | Zubsolv |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.91 | 2022 | |
| Lilly USA, LLC | $35.71 | 2022-2025 | Zepbound, Mounjaro |
| Ultragenyx Pharmaceutical INC. | $35.22 | 2021 | |
| Virtus Pharmaceuticals LLC | $26.61 | 2021 | |
| Redhill Biopharma INC. | $20.89 | 2021 | |
| Xeris Pharmaceuticals, INC. | $20.74 | 2021 | |
| Ardelyx, INC. | $20.04 | 2023 | Ibsrela |
| Biohaven Pharmaceutical Holding Company LTD. | $19.36 | 2022 | |
| Ibsa Pharma INC. | $18.06 | 2025 | Licart, Tirosint, Flector |
| Actelion Pharmaceuticals US, INC. | $16.61 | 2025 | Opsumit, Uptravi |
| Paratek Pharmaceuticals, INC. | $14.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.39 | 2022 | |
| Novartis Pharmaceuticals Corporation | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.